Join
Live feed
·
INSIDERFilingvia Quantisnow
Oncternal Therapeutics Inc. logo

Wills Robert James sold $8,859 worth of shares (980 units at $9.04), closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ONCT· Oncternal Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ONCT (Oncternal Therapeutics Inc.) and more on Quantisnow.